Frontiers in Immunology

Papers
(The TQCC of Frontiers in Immunology is 11. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19)1679
The COVID-19 Cytokine Storm; What We Know So Far1106
Cytokine Storm in COVID-19: The Current Evidence and Treatment Strategies762
Tumor-Associated Macrophages in Tumor Immunity742
The Genus Alistipes: Gut Bacteria With Emerging Implications to Inflammation, Cancer, and Mental Health731
Immune Response, Inflammation, and the Clinical Spectrum of COVID-19475
Cancer Stem Cells—Origins and Biomarkers: Perspectives for Targeted Personalized Therapies422
The Tumor Microenvironment: A Milieu Hindering and Obstructing Antitumor Immune Responses412
Cancer Immune Evasion Through Loss of MHC Class I Antigen Presentation376
A Review of the Progress and Challenges of Developing a Vaccine for COVID-19346
Cytokine Storm in COVID-19—Immunopathological Mechanisms, Clinical Considerations, and Therapeutic Approaches: The REPROGRAM Consortium Position Paper346
IOBR: Multi-Omics Immuno-Oncology Biological Research to Decode Tumor Microenvironment and Signatures327
Quercetin and Vitamin C: An Experimental, Synergistic Therapy for the Prevention and Treatment of SARS-CoV-2 Related Disease (COVID-19)324
Overview of Immune Response During SARS-CoV-2 Infection: Lessons From the Past321
Targeting the NLRP3 Inflammasome in Severe COVID-19316
The Gut-Brain Axis: How Microbiota and Host Inflammasome Influence Brain Physiology and Pathology315
The Tumor Microenvironment in the Response to Immune Checkpoint Blockade Therapies314
Redefining Tumor-Associated Macrophage Subpopulations and Functions in the Tumor Microenvironment312
Targeting Inflammation Driven by HMGB1310
Comparative Review of SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza A Respiratory Viruses305
The SARS-CoV-2 Spike Glycoprotein Biosynthesis, Structure, Function, and Antigenicity: Implications for the Design of Spike-Based Vaccine Immunogens297
Phagocytosis: Our Current Understanding of a Universal Biological Process284
Mucosal Immunity in COVID-19: A Neglected but Critical Aspect of SARS-CoV-2 Infection282
Interferon-α2b Treatment for COVID-19281
Relationships Between Immune Landscapes, Genetic Subtypes and Responses to Immunotherapy in Colorectal Cancer275
Pulmonary Innate Immune Response Determines the Outcome of Inflammation During Pneumonia and Sepsis-Associated Acute Lung Injury272
Gut Microbiota as a Trigger for Metabolic Inflammation in Obesity and Type 2 Diabetes269
Anti-Inflammatory and Immunomodulatory Effects of Probiotics in Gut Inflammation: A Door to the Body268
Maternal Immunological Adaptation During Normal Pregnancy260
Interplay Between NLRP3 Inflammasome and Autophagy258
Interaction of Microglia and Astrocytes in the Neurovascular Unit254
The Intestinal Microbiota and Colorectal Cancer249
Dendritic Cells and Their Role in Immunotherapy245
Highlight of Immune Pathogenic Response and Hematopathologic Effect in SARS-CoV, MERS-CoV, and SARS-Cov-2 Infection241
The Emerging Role of Neutrophil Extracellular Traps (NETs) in Tumor Progression and Metastasis237
The Biology of Lactoferrin, an Iron-Binding Protein That Can Help Defend Against Viruses and Bacteria236
The Potential Impact of Zinc Supplementation on COVID-19 Pathogenesis233
COVID-19 Coronavirus Vaccine Design Using Reverse Vaccinology and Machine Learning232
Myeloid Cell-Derived Arginase in Cancer Immune Response230
The Effects of Type 2 Diabetes Mellitus on Organ Metabolism and the Immune System217
Crosstalk Between Astrocytes and Microglia: An Overview216
Interleukin-6 Is a Biomarker for the Development of Fatal Severe Acute Respiratory Syndrome Coronavirus 2 Pneumonia211
Growth/Differentiation Factor-15 (GDF-15): From Biomarker to Novel Targetable Immune Checkpoint211
The Rise of Non-Tuberculosis Mycobacterial Lung Disease211
Reaction of Human Monoclonal Antibodies to SARS-CoV-2 Proteins With Tissue Antigens: Implications for Autoimmune Diseases210
T Helper (Th) Cell Profiles in Pregnancy and Recurrent Pregnancy Losses: Th1/Th2/Th9/Th17/Th22/Tfh Cells205
NF-κB: At the Borders of Autoimmunity and Inflammation205
Mucins in Intestinal Mucosal Defense and Inflammation: Learning From Clinical and Experimental Studies203
Localized Interleukin-12 for Cancer Immunotherapy202
SARS-CoV-2 Accessory Proteins in Viral Pathogenesis: Knowns and Unknowns198
Serological Approaches for COVID-19: Epidemiologic Perspective on Surveillance and Control196
Neutrophils in COVID-19195
Immune-Boosting, Antioxidant and Anti-inflammatory Food Supplements Targeting Pathogenesis of COVID-19194
Human Immune Responses to Adeno-Associated Virus (AAV) Vectors193
A Path Toward Precision Medicine for Neuroinflammatory Mechanisms in Alzheimer's Disease191
Colorectal Cancer Immunotherapy: Options and Strategies187
The New Era of Cancer Immunotherapy: Targeting Myeloid-Derived Suppressor Cells to Overcome Immune Evasion183
Humoral Responses and Serological Assays in SARS-CoV-2 Infections180
Crosstalk Between the MSI Status and Tumor Microenvironment in Colorectal Cancer179
ACE2/ADAM17/TMPRSS2 Interplay May Be the Main Risk Factor for COVID-19175
Excessive Neutrophils and Neutrophil Extracellular Traps in COVID-19175
Role of Metabolic Endotoxemia in Systemic Inflammation and Potential Interventions175
The Nexus Between Periodontal Inflammation and Dysbiosis174
The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization Strategies174
The Role of Inflammation in Diabetic Retinopathy172
Regulation of PD-L1 Expression by NF-κB in Cancer172
Macrophages: The Good, the Bad, and the Gluttony171
SARS-CoV-2 Variants, Vaccines, and Host Immunity169
Macrophage Polarization and Its Role in Liver Disease169
TLR4 Cross-Talk With NLRP3 Inflammasome and Complement Signaling Pathways in Alzheimer's Disease168
Aspects of the Tumor Microenvironment Involved in Immune Resistance and Drug Resistance166
Impact of Bacterial Metabolites on Gut Barrier Function and Host Immunity: A Focus on Bacterial Metabolism and Its Relevance for Intestinal Inflammation165
Severe COVID-19: NLRP3 Inflammasome Dysregulated164
Acute Transverse Myelitis (ATM):Clinical Review of 43 Patients With COVID-19-Associated ATM and 3 Post-Vaccination ATM Serious Adverse Events With the ChAdOx1 nCoV-19 Vaccine (AZD1222)163
The Role of PD-1 in Acute and Chronic Infection161
CD8+ T Cell Exhaustion in Cancer159
Monocytes and Macrophages in COVID-19158
Remodeling of the Immune Response With Aging: Immunosenescence and Its Potential Impact on COVID-19 Immune Response158
Tumor-Infiltrating Lymphocytes and Their Prognostic Value in Cutaneous Melanoma158
CAR-T Cells Hit the Tumor Microenvironment: Strategies to Overcome Tumor Escape157
The Role of Calcium–Calcineurin–NFAT Signaling Pathway in Health and Autoimmune Diseases156
T Cells in Fibrosis and Fibrotic Diseases156
Epstein-Barr Virus and Systemic Autoimmune Diseases154
Emerging Concepts and Technologies in Vaccine Development154
B and T Cells Driving Multiple Sclerosis: Identity, Mechanisms and Potential Triggers153
Molecular Heterogeneity and Immunosuppressive Microenvironment in Glioblastoma152
Role of Vascular Smooth Muscle Cell Plasticity and Interactions in Vessel Wall Inflammation150
Toll-Like Receptor Signaling and Its Role in Cell-Mediated Immunity149
Phagocytosis of Apoptotic Cells in Resolution of Inflammation148
SARS-CoV-2 Vaccines Based on the Spike Glycoprotein and Implications of New Viral Variants147
Increased sCD163 and sCD14 Plasmatic Levels and Depletion of Peripheral Blood Pro-Inflammatory Monocytes, Myeloid and Plasmacytoid Dendritic Cells in Patients With Severe COVID-19 Pneumonia146
Metabolic Reprograming of Microglia in the Regulation of the Innate Inflammatory Response146
Identification of SARS-CoV-2 Cell Entry Inhibitors by Drug Repurposing Using in silico Structure-Based Virtual Screening Approach146
Unraveling the Mystery Surrounding Post-Acute Sequelae of COVID-19146
Neurotoxicity and Cytokine Release Syndrome After Chimeric Antigen Receptor T Cell Therapy: Insights Into Mechanisms and Novel Therapies144
Intestinal Flora and Disease Mutually Shape the Regional Immune System in the Intestinal Tract143
NLRP3 Inflammasome Activation in Cancer: A Double-Edged Sword142
NF-κB Pathway as a Potential Target for Treatment of Critical Stage COVID-19 Patients141
Phage Display Derived Monoclonal Antibodies: From Bench to Bedside141
Adjuvants for Coronavirus Vaccines139
Role of the IL-23/IL-17 Pathway in Rheumatic Diseases: An Overview138
Different Innate and Adaptive Immune Responses to SARS-CoV-2 Infection of Asymptomatic, Mild, and Severe Cases138
Immunotherapy for Ovarian Cancer: Adjuvant, Combination, and Neoadjuvant138
COVID-19: Coronavirus Vaccine Development Updates138
Research Advances in How the cGAS-STING Pathway Controls the Cellular Inflammatory Response137
Anti-angiogenic Agents in Combination With Immune Checkpoint Inhibitors: A Promising Strategy for Cancer Treatment137
Novel Coronavirus-Induced NLRP3 Inflammasome Activation: A Potential Drug Target in the Treatment of COVID-19137
Efficacy, Immunogenicity and Safety of COVID-19 Vaccines: A Systematic Review and Meta-Analysis135
Exhausted CD8+T Cells in the Tumor Immune Microenvironment: New Pathways to Therapy135
The Chemokine Receptor CXCR4 in Cell Proliferation and Tissue Regeneration134
IL-1β and the Intestinal Epithelial Tight Junction Barrier134
The Global Epidemic of the SARS-CoV-2 Delta Variant, Key Spike Mutations and Immune Escape133
The Lung Macrophage in SARS-CoV-2 Infection: A Friend or a Foe?133
An Attempt to Polarize Human Neutrophils Toward N1 and N2 Phenotypes in vitro133
The IL-23/IL-17 Pathway in Inflammatory Skin Diseases: From Bench to Bedside132
Myeloid-Derived Suppressor Cells in Tumors: From Mechanisms to Antigen Specificity and Microenvironmental Regulation131
Genetics Insight for COVID-19 Susceptibility and Severity: A Review131
Probiotics in Medicine: A Long Debate131
Multiple Roles for Chemokines in Neutrophil Biology131
Microbiota Modulation of the Gut-Lung Axis in COVID-19131
Gamma-Delta CAR-T Cells Show CAR-Directed and Independent Activity Against Leukemia130
Reactive Oxygen Species in Macrophages: Sources and Targets130
Overview: Systemic Inflammatory Response Derived From Lung Injury Caused by SARS-CoV-2 Infection Explains Severe Outcomes in COVID-19129
Versican—A Critical Extracellular Matrix Regulator of Immunity and Inflammation129
Omicron: A Heavily Mutated SARS-CoV-2 Variant Exhibits Stronger Binding to ACE2 and Potently Escapes Approved COVID-19 Therapeutic Antibodies129
Immune Cells in the BBB Disruption After Acute Ischemic Stroke: Targets for Immune Therapy?128
The Roles of Inflammation in Keloid and Hypertrophic Scars128
The Immune Response and Immunopathology of COVID-19128
CD38: An Immunomodulatory Molecule in Inflammation and Autoimmunity127
Maternal-Fetal Inflammation in the Placenta and the Developmental Origins of Health and Disease126
Augmenting Anticancer Immunity Through Combined Targeting of Angiogenic and PD-1/PD-L1 Pathways: Challenges and Opportunities126
Microglia and Inflammatory Responses in Diabetic Retinopathy126
Immunosuppressive IDO in Cancer: Mechanisms of Action, Animal Models, and Targeting Strategies126
Contriving Multi-Epitope Subunit of Vaccine for COVID-19: Immunoinformatics Approaches126
Cuproptosis-Related Risk Score Predicts Prognosis and Characterizes the Tumor Microenvironment in Hepatocellular Carcinoma125
Microglia in Multiple Sclerosis: Friend or Foe?125
CXCR3 Ligands in Cancer and Autoimmunity, Chemoattraction of Effector T Cells, and Beyond124
The Oral Microbiome and Cancer124
The Paneth Cell: The Curator and Defender of the Immature Small Intestine124
Immunosuppressive Mechanisms of Regulatory B Cells123
Partners in Leaky Gut Syndrome: Intestinal Dysbiosis and Autoimmunity122
What’s Sex Got to Do With COVID-19? Gender-Based Differences in the Host Immune Response to Coronaviruses122
Anti-Phospholipid Antibodies in COVID-19 Are Different From Those Detectable in the Anti-Phospholipid Syndrome121
Bispecific Antibodies: From Research to Clinical Application120
Sex Differences in Immunity to Viral Infections120
Structure-Functional Activity Relationship of β-Glucans From the Perspective of Immunomodulation: A Mini-Review120
T-Cell Hyperactivation and Paralysis in Severe COVID-19 Infection Revealed by Single-Cell Analysis120
The Role of Macrophages in Staphylococcus aureus Infection119
Tumor Necrosis Factor Receptors: Pleiotropic Signaling Complexes and Their Differential Effects119
MSC Therapies for COVID-19: Importance of Patient Coagulopathy, Thromboprophylaxis, Cell Product Quality and Mode of Delivery for Treatment Safety and Efficacy119
Differentiation and Regulation of TH Cells: A Balancing Act for Cancer Immunotherapy118
Protective Functions of Reactive Astrocytes Following Central Nervous System Insult118
Hepatocellular Carcinoma Immune Landscape and the Potential of Immunotherapies117
The Role of Natural Killer Cells in Autoimmune Diseases117
Interaction Between Virus-Like Particles (VLPs) and Pattern Recognition Receptors (PRRs) From Dendritic Cells (DCs): Toward Better Engineering of VLPs116
Flattening the COVID-19 Curve With Natural Killer Cell Based Immunotherapies116
The Impact of Pre-existing Comorbidities and Therapeutic Interventions on COVID-19116
TERT—Regulation and Roles in Cancer Formation116
Sexual Dimorphism in Innate Immunity: The Role of Sex Hormones and Epigenetics115
Regulation of MAVS Expression and Signaling Function in the Antiviral Innate Immune Response115
Persistence of SARS CoV-2 S1 Protein in CD16+ Monocytes in Post-Acute Sequelae of COVID-19 (PASC) up to 15 Months Post-Infection115
The Role of M1/M2 Macrophage Polarization in Rheumatoid Arthritis Synovitis115
Controlling Cytokine Storm Is Vital in COVID-19114
The Immature Gut Barrier and Its Importance in Establishing Immunity in Newborn Mammals113
IL-15 in the Combination Immunotherapy of Cancer112
Modulation of Immune Responses by Particle Size and Shape112
Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma112
A Bibliometric Analysis of Pyroptosis From 2001 to 2021111
I mmunosenescence and Inflammaging: Risk Factors of Severe COVID-19 in Older People111
A Comprehensive Review of Viral Characteristics, Transmission, Pathophysiology, Immune Response, and Management of SARS-CoV-2 and COVID-19 as a Basis for Controlling the Pandemic110
Interleukin-17 in Chronic Inflammatory Neurological Diseases110
The Use of Immune Checkpoint Inhibitors in Oncology and the Occurrence of AKI: Where Do We Stand?109
Gallic Acid Alleviates Gouty Arthritis by Inhibiting NLRP3 Inflammasome Activation and Pyroptosis Through Enhancing Nrf2 Signaling109
Defensins: A Double-Edged Sword in Host Immunity109
Transcriptional Regulators of T Helper 17 Cell Differentiation in Health and Autoimmune Diseases108
Neoantigen: A New Breakthrough in Tumor Immunotherapy108
The NF-κB Signaling Pathway, the Microbiota, and Gastrointestinal Tumorigenesis: Recent Advances108
Immunoglobulins, Mucosal Immunity and Vaccination in Teleost Fish108
Role of Human Milk Bioactives on Infants' Gut and Immune Health108
More Than Just a Barrier: The Immune Functions of the Airway Epithelium in Asthma Pathogenesis107
Research Progress in Atopic March107
Cytokines in CAR T Cell–Associated Neurotoxicity106
Targeting GM-CSF in COVID-19 Pneumonia: Rationale and Strategies106
Digital Twins for Multiple Sclerosis106
Cancer-Associated Fibroblasts-Derived Exosomes Suppress Immune Cell Function in Breast Cancer via the miR-92/PD-L1 Pathway106
Covid-19: Perspectives on Innate Immune Evasion106
Janus Kinase Inhibition Ameliorates Ischemic Stroke Injury and Neuroinflammation Through Reducing NLRP3 Inflammasome Activation via JAK2/STAT3 Pathway Inhibition105
Lectin Pathway Mediates Complement Activation by SARS-CoV-2 Proteins105
Cells of the Immune System in Cardiac Remodeling: Main Players in Resolution of Inflammation and Repair After Myocardial Infarction105
Prediction of Specific TCR-Peptide Binding From Large Dictionaries of TCR-Peptide Pairs105
IL-10 and IL-22 in Mucosal Immunity: Driving Protection and Pathology104
C-Reactive Protein and Cancer—Diagnostic and Therapeutic Insights104
Dermatomyositis With Anti-MDA5 Antibodies: Bioclinical Features, Pathogenesis and Emerging Therapies104
T Cell Metabolism: A New Perspective on Th17/Treg Cell Imbalance in Systemic Lupus Erythematosus103
Cross-Talk Between Alveolar Macrophages and Lung Epithelial Cells is Essential to Maintain Lung Homeostasis103
Causal Relationship Between Gut Microbiota and Autoimmune Diseases: A Two-Sample Mendelian Randomization Study103
IDO Expression in Cancer: Different Compartment, Different Functionality?102
Oxidative Stress in Ozone-Induced Chronic Lung Inflammation and Emphysema: A Facet of Chronic Obstructive Pulmonary Disease102
Immunomodulatory and Regenerative Effects of Mesenchymal Stem Cells and Extracellular Vesicles: Therapeutic Outlook for Inflammatory and Degenerative Diseases102
Kaempferol Alleviates Murine Experimental Colitis by Restoring Gut Microbiota and Inhibiting the LPS-TLR4-NF-κB Axis102
Symptomatic Protective Action of Glycyrrhizin (Licorice) in COVID-19 Infection?101
Innate Immune Signaling and Proteolytic Pathways in the Resolution or Exacerbation of SARS-CoV-2 in Covid-19: Key Therapeutic Targets?101
Tryptophan Metabolic Pathways Are Altered in Obesity and Are Associated With Systemic Inflammation101
Single-Cell Atlas Reveals Complexity of the Immunosuppressive Microenvironment of Initial and Recurrent Glioblastoma100
Astragalin Attenuates Dextran Sulfate Sodium (DSS)-Induced Acute Experimental Colitis by Alleviating Gut Microbiota Dysbiosis and Inhibiting NF-κB Activation in Mice100
Immune-Based Prediction of COVID-19 Severity and Chronicity Decoded Using Machine Learning100
Antigen Cross-Presentation by Macrophages99
Construction of a Ferroptosis-Related Nine-lncRNA Signature for Predicting Prognosis and Immune Response in Hepatocellular Carcinoma99
Antibody Responses in COVID-19: A Review99
IgE and IgG Antibodies as Regulators of Mast Cell and Basophil Functions in Food Allergy99
Alterations in Circulating Fatty Acid Are Associated With Gut Microbiota Dysbiosis and Inflammation in Multiple Sclerosis98
SARS-CoV-2 Membrane Protein Inhibits Type I Interferon Production Through Ubiquitin-Mediated Degradation of TBK198
Importance of Type I and III Interferons at Respiratory and Intestinal Barrier Surfaces98
Exosome-Based Vaccines: History, Current State, and Clinical Trials98
Toll-Like Receptor 4 (TLR4)/Opioid Receptor Pathway Crosstalk and Impact on Opioid Analgesia, Immune Function, and Gastrointestinal Motility97
Combining Oncolytic Viruses With Cancer Immunotherapy: Establishing a New Generation of Cancer Treatment97
The Extrinsic and Intrinsic Roles of PD-L1 and Its Receptor PD-1: Implications for Immunotherapy Treatment97
Psycho-Neuroendocrine-Immune Interactions in COVID-19: Potential Impacts on Mental Health97
Vertically Transferred Immunity in Neonates: Mothers, Mechanisms and Mediators97
TIGIT, the Next Step Towards Successful Combination Immune Checkpoint Therapy in Cancer97
The Molecular Mechanisms That Underlie the Immune Biology of Anti-drug Antibody Formation Following Treatment With Monoclonal Antibodies97
Risk Factors and Biomarkers for Immune-Related Adverse Events: A Practical Guide to Identifying High-Risk Patients and Rechallenging Immune Checkpoint Inhibitors96
Diagnosis and Management of Secondary HLH/MAS Following HSCT and CAR-T Cell Therapy in Adults; A Review of the Literature and a Survey of Practice Within EBMT Centres on Behalf of the Autoimmune Disea96
Immunotherapy in Lung Cancer: Current Landscape and Future Directions96
Targeting Inflammation and Immunosenescence to Improve Vaccine Responses in the Elderly96
Addressing Parental Vaccine Hesitancy and Other Barriers to Childhood/Adolescent Vaccination Uptake During the Coronavirus (COVID-19) Pandemic96
Immune and Metabolic Signatures of COVID-19 Revealed by Transcriptomics Data Reuse96
FcγR Binding and ADCC Activity of Human IgG Allotypes96
Type I Interferon (IFN)-Regulated Activation of Canonical and Non-Canonical Signaling Pathways96
Adoptive Cell Therapy Targeting Neoantigens: A Frontier for Cancer Research95
B Cell Subsets as Severity-Associated Signatures in COVID-19 Patients95
The Important Interface Between Apolipoprotein E and Neuroinflammation in Alzheimer’s Disease95
Immunogenicity Risk Profile of Nanobodies95
Mechanisms of Key Innate Immune Cells in Early- and Late-Onset Preeclampsia94
Factors Which Contribute to the Immunogenicity of Non-replicating Adenoviral Vectored Vaccines94
Elevated Interleukin-10 Levels in COVID-19: Potentiation of Pro-Inflammatory Responses or Impaired Anti-Inflammatory Action?94
Lactate Suppresses Macrophage Pro-Inflammatory Response to LPS Stimulation by Inhibition of YAP and NF-κB Activation via GPR81-Mediated Signaling94
B7-H3/CD276: An Emerging Cancer Immunotherapy93
Fc Gamma Receptors and Their Role in Antigen Uptake, Presentation, and T Cell Activation93
Role of MIF Cytokine/CD74 Receptor Pathway in Protecting Against Injury and Promoting Repair92
Immunogenic Cell Death Induction by Ionizing Radiation92
IDO and Kynurenine Metabolites in Peripheral and CNS Disorders92
Causal Effects of Gut Microbiome on Systemic Lupus Erythematosus: A Two-Sample Mendelian Randomization Study91
Increased Plasma Heparanase Activity in COVID-19 Patients91
Roles of Macrophage Polarization and Macrophage-Derived miRNAs in Pulmonary Fibrosis91
Diversity of Macrophages in Lung Homeostasis and Diseases91
The Long History of Vitamin C: From Prevention of the Common Cold to Potential Aid in the Treatment of COVID-1991
Association of HLA Class I Genotypes With Severity of Coronavirus Disease-1990
Opioid Receptors in Immune and Glial Cells—Implications for Pain Control90
Effect of Hepatic Macrophage Polarization and Apoptosis on Liver Ischemia and Reperfusion Injury During Liver Transplantation90
0.038619041442871